Long-Term Results of Single-Anastomosis Duodeno-ileal Bypass with Sleeve Gastrectomy (SADI-S)

• DOI: 10.1007/s11695-021-05879-9
• Publication Date: 2022-01-15T10:02:48Z
• Authors: Andrés Sánchez-Pe...; Miguel Ángel Rubi...; Natalia Pérez Ferré; Carlos Sáez Rodrí...; Clara Marcuello; Clara Pañella; Leyre Lopez Antoñ...; Antonio Torres; Elia Pérez-Aguirre
• Keywords: Gastroenterología y hepatología; Hypoabsorption; Duodenum; Anastomosis, Surgical; Gastric Bypass; Original Contribution; Sleeve; Middle Aged; SADI-S; Obesity, Morbid; 3. Good health; 03 medical and health sciences; Duodenal switch; 0302 clinical medicine; Diabetes Mellitus, Type 2; Gastrectomy; Weight Loss; Humans; Insulin; Duodeno-ileostom; 3205.03 Gastroenterología; Retrospective Studies

Abstract Background Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) is a simplification of the duodenal switch (DS) in which the alimentary limb is eliminated, and the common channel is lengthened from 200 to 300 cm. Short-term results have demonstrated that SADI-S is safe and reproducible and that weight loss and comorbidities resolution are comparable to biliopancreatic diversion or DS.

Objective To analyze the long-term outcomes of SADI-S.

Methods

From May 2007 to December 2015, 164 patients were consecutively submitted to a one-step SADI-S. The mean age was 47 years, and the mean body mass index (BMI) was 45.8 kg/m2. A total of 101 patients had type 2 diabetes, 91 arterial hypertension, 81 obstructive apnea, and 118 dyslipidemia. Limb length was 200 cm in 50 cases, 250 cm in 99, and 300 cm in 15.

Results There was no mortality. One patient had a gastric leak, and 2 patients had an anastomotic leak. A total of 25% of the patients were lost to follow-up at 10 years. Excess weight loss and total weight loss were 87% and 38% at 5 years and 80% and 34% at 10 years. A total of 12 patients were submitted to revisional surgery for hypoproteinemia. Preoperatively 41 diabetics were under insulin treatment; at 5 years, 7 remained with insulin and 12 at 10 years. Mean glycemia was 104 mg/dL at 5 years and 118 mg/dL at 10 years. Mean HbA1c was 5.51% at 5 years and 5.86 at 10 years.

Conclusion In the long term, SADI-S offers satisfactory weight loss and comorbidities resolution.

Graphical Abstract